...We Welcome You to the Zenith Epigenetics Hub withIn The AGORACOM COMMUNITY!

Zenith's BET Inhibitor ZEN-3694 is Currently Being Evaluated in Multiple Oncology Clinical Trials

Free
Message: Re: Eligibility for registered accounts in Canada

Thanks,

I did find the section Sarah quoted in the SEDAR doc.

It seems to be an interesting legal question.

So far, the CRA has let it go but if Zenith sells for a huge premium some of us may be getting audited.

Hopefully, the company can give me ongoing clarity.

 

bfw

Share
New Message
Please login to post a reply